Table 1 Baseline characteristics of included patients
Intervention (n = 64) | Control (n = 23) | p-value* | ||
|---|---|---|---|---|
Inclusion diagnosis | ||||
Severe depression | 29 (45.3) | 10 (43.5) | ||
Bipolar disorder | 18 (28.1) | 8 (34.8) | 0.8 | |
Schizophrenia | 17 (26.6) | 5 (21.7) | ||
Gender | ||||
Female | 41 (64.1) | 18 (78.3) | 0.2 | |
Male | 23 (35.9) | 5 (21.7) | ||
Age | ||||
18–24 | 3 (4.7) | 1 (4.4) | ||
25–34 | 14 (21.8) | 4 (17.4) | ||
35–44 | 5 (7.8) | 5 (21.7) | ||
45–54 | 16 (25.0) | 5 (21.7) | 0.7 | |
55–64 | 12 (18.8) | 4 (17.4) | ||
≥ 65 | 14 (21.9) | 4 (17.4) | ||
Region of residence | ||||
Capital | 36 (56.3) | 13 (56.5) | 1.0 | |
Zealand | 28 (43.8) | 10 (43.5) | ||
Other medical conditions | ||||
Other mental illness | 28 (43.8) | 6 (26.1) | 0.1 | |
Substance use disorder | 7 (10.9) | 3 (13) | 0.8 | |
Cardiovascular disease | 9 (14.1) | 2 (8.7) | 0.5 | |
Hypertension | 13 (20.3) | 6 (26.1) | 0.6 | |
Diabetes | 7 (10.9) | 1 (4.4) | 0.3 | |
BMI > 25 | 17 (26.6) | 5 (21.7) | 0.6 | |
Smoking | 7 (10.9) | 2 (8.7) | 0.8 | |
COPD/ asthma | 14 (21.9) | 3 (13.0) | 0.4 | |
Metabolic disorder | 6 (9.4) | 2 (8.7) | 0.9 | |
Musculoskeletal disease | 16 (25.0) | 5 (21.7) | 0.8 | |
Neurological disease | 4 (6.3) | 2 (8.7) | 0.7 | |
Cancer | 1 (1.6) | 1 (4.4) | 0.4 | |
Other | 14 (21.9) | 0 (0.0) | 0.01 | |
Contacts to the clinic in preceding year | ||||
0–5 | 15 (23.4) | 2 (8.7) | ||
6–10 | 17 (26.6) | 2 (8.7) | ||
11–15 | 11 (17.2) | 6 (26.1) | 0.06 | |
16–20 | 3 (4.7) | 5 (21.7) | ||
>20 | 16 (25.0) | 7 (30.4) | ||
Missing value | 2 (3.1) | 1 (4.4) | ||